We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Celanese Inks Deal With Linde to Buy Syngas Production Unit
Read MoreHide Full Article
Celanese Corporation (CE - Free Report) has entered into a definitive agreement to purchase a synthesis gas production unit of 365 kilo tons per annum from Linde PLC. The unit is located at the Celanese Clear Lake acetyl intermediates manufacturing facility in Pasadena, TX.
Syngas is a combination of carbon dioxide, carbon monoxide and hydrogen. It can be produced from sources like coal, biomass, natural gas, or any hydrocarbon feedstock, with the reaction of oxygen or steam. Moreover, syngas is an important resource for the production of ammonia, acetic acid, methanol, synthetic hydrocarbon fuels and hydrogen.
With this acquisition, Celanese will now have the capacity to produce a key raw material for the world’s largest acetyl intermediates production facility. Linde is the primary supplier of carbon monoxide to the Clear Lake facility and the acquisition of syngas production unit is likely to open up productivity and growth opportunities for Celanese.
Celanese and Linde are expected to complete the deal upon meeting customary closing conditions and receiving regulatory approvals. However, the financial details of the deal have been kept under wraps.
In the past six months, Celanese has underperformed the industry it belongs to. The stock has lost around 14.7% compared with the industry’s fall of 8.9%.
Celanese, in October 2018, raised its adjusted earnings per share guidance for 2018 to $10.90-$11.10, owing to strength in Engineered Materials (EM) and Acetyl Chain units. The company expects momentum in Acetyl Chain and EM to continue. The EM segment is expected to maintain the pace of earnings growth with traction from new projects and bolt-on acquisitions.
Celanese is taking appropriate pricing actions amid a volatile pricing environment for raw materials. The company’s strategic measures including operational cost savings through productivity actions and price hike initiatives are likely to provide an impetus to earnings.
Celanese currently carries a Zacks Rank #4 (Sell).
A few better-ranked stocks in the basic materials space are Ingevity Corporation (NGVT - Free Report) , Israel Chemicals Ltd. (ICL - Free Report) and Cameco Corporation (CCJ - Free Report) .
Ingevity’s shares have gained 19% in the past year. The company has an expected earnings growth rate of 21.5% for 2019 and it currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Israel Chemicals has an expected earnings growth rate of 2.7% for 2019 and a Zacks Rank #2 (Buy). The stock has rallied 30.4% in a year.
Cameco has an expected earnings growth rate of 20% for 2019 and a Zacks Rank #2. Its shares have gained 28.5% in a year.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Celanese Inks Deal With Linde to Buy Syngas Production Unit
Celanese Corporation (CE - Free Report) has entered into a definitive agreement to purchase a synthesis gas production unit of 365 kilo tons per annum from Linde PLC. The unit is located at the Celanese Clear Lake acetyl intermediates manufacturing facility in Pasadena, TX.
Syngas is a combination of carbon dioxide, carbon monoxide and hydrogen. It can be produced from sources like coal, biomass, natural gas, or any hydrocarbon feedstock, with the reaction of oxygen or steam. Moreover, syngas is an important resource for the production of ammonia, acetic acid, methanol, synthetic hydrocarbon fuels and hydrogen.
With this acquisition, Celanese will now have the capacity to produce a key raw material for the world’s largest acetyl intermediates production facility. Linde is the primary supplier of carbon monoxide to the Clear Lake facility and the acquisition of syngas production unit is likely to open up productivity and growth opportunities for Celanese.
Celanese and Linde are expected to complete the deal upon meeting customary closing conditions and receiving regulatory approvals. However, the financial details of the deal have been kept under wraps.
In the past six months, Celanese has underperformed the industry it belongs to. The stock has lost around 14.7% compared with the industry’s fall of 8.9%.
Celanese, in October 2018, raised its adjusted earnings per share guidance for 2018 to $10.90-$11.10, owing to strength in Engineered Materials (EM) and Acetyl Chain units. The company expects momentum in Acetyl Chain and EM to continue. The EM segment is expected to maintain the pace of earnings growth with traction from new projects and bolt-on acquisitions.
Celanese is taking appropriate pricing actions amid a volatile pricing environment for raw materials. The company’s strategic measures including operational cost savings through productivity actions and price hike initiatives are likely to provide an impetus to earnings.
Celanese Corporation Price and Consensus
Celanese Corporation Price and Consensus | Celanese Corporation Quote
Zacks Rank & Stocks to Consider
Celanese currently carries a Zacks Rank #4 (Sell).
A few better-ranked stocks in the basic materials space are Ingevity Corporation (NGVT - Free Report) , Israel Chemicals Ltd. (ICL - Free Report) and Cameco Corporation (CCJ - Free Report) .
Ingevity’s shares have gained 19% in the past year. The company has an expected earnings growth rate of 21.5% for 2019 and it currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Israel Chemicals has an expected earnings growth rate of 2.7% for 2019 and a Zacks Rank #2 (Buy). The stock has rallied 30.4% in a year.
Cameco has an expected earnings growth rate of 20% for 2019 and a Zacks Rank #2. Its shares have gained 28.5% in a year.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>